Medicare Enrolled

Dr. Benjamin Havemann, M.D.

Gastroenterology · Austin, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
4310 JAMES CASEY ST, Austin, TX 78745
5124484588
In practice since 2006 (19 years)
NPI: 1154347870 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Havemann from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Havemann? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Havemann

Dr. Benjamin Havemann is a gastroenterology in Austin, TX, with 19 years in practice. Based on federal Medicare data, Dr. Havemann performed 967 Medicare services across 946 unique beneficiaries.

Between the years covered by Open Payments, Dr. Havemann received a total of $26,890 from 43 pharmaceutical and/or device companies across 528 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Havemann is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 25% volume in TX$ $26,890 industry payments

Medicare Practice Summary

Medicare Utilization ↗
967
Medicare services
Top 25% in TX for gastroenterology
946
Unique beneficiaries
$119
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~51 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Removal of polyps or growths of large bowel using an endoscope with mechanical snare231$189$1,171
Colonoscopy with biopsy171$67$883
Upper GI endoscopy with biopsy143$71$592
Office visit, established patient (20-29 min)99$62$160
Office visit, established patient (30-39 min)76$97$235
New patient office visit (30-44 min)61$70$235
Colorectal cancer screening; colonoscopy on individual at high risk46$179$803
New patient office visit (45-59 min)34$128$365
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk22$171$818
Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope19$70$575
Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm18$74$637
Diagnostic exam of large bowel using a flexible endoscope16$134$818
Imaging of digestive tract done from the inside of the digestive tract16$593$2,200
Initial hospital admission, moderate complexity15$102$310
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$26,890
Total received (2018-2024)
Avg $3,841/year across 7 years
Top 9% in TX for gastroenterology
43
Companies
528
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$16,017 (59.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,873 (40.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,524
2023
$9,047
2022
$2,229
2021
$10,527
2020
$438
2019
$1,515
2018
$1,610

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$8,792
Ferring Pharmaceuticals Inc.
$7,306
Celgene Corporation
$1,893
ABBVIE INC.
$1,575
AbbVie Inc.
$840
AbbVie, Inc.
$728
Janssen Scientific Affairs, LLC
$707
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$704
PFIZER INC.
$546
Janssen Biotech, Inc.
$466
Regeneron Healthcare Solutions, Inc.
$431
Takeda Pharmaceuticals U.S.A., Inc.
$267
Ardelyx, Inc.
$240
Allergan Inc.
$226
Gilead Sciences, Inc.
$188
Lumendi LLC
$167
Nestle HealthCare Nutrition Inc.
$158
Romark Laboratories, LC
$156
Ethicon Inc.
$122
RedHill Biopharma Inc.
$119
Ironwood Pharmaceuticals, Inc
$117
Ethicon US, LLC
$92
Braintree Laboratories, Inc.
$91
CONMED Corporation
$87
GENZYME CORPORATION
$86
UCB, Inc.
$86
Merck Sharp & Dohme Corporation
$83
IRONWOOD PHARMACEUTICALS, INC
$79
Phathom Pharmaceuticals, Inc.
$79
AIMMUNE THERAPEUTICS, INC.
$72
Endogastric Solutions, Inc
$62
Madrigal Pharmaceuticals
$46
Allergan, Inc.
$44
QOL Medical, LLC
$39
VIVUS LLC
$36
Merck Sharp & Dohme LLC
$30
BOSTON SCIENTIFIC CORPORATION
$24
Prometheus Laboratories Inc.
$24
Alfasigma USA, Inc.
$18
Intercept Pharmaceuticals, Inc.
$17
Lilly USA, LLC
$17
NESTLE HEALTHCARE NUTRITION INC.
$16
INTERCEPT PHARMACEUTICALS, INC.
$15
Top 3 companies account for 66.9% of total payments
Associated products mentioned in payments ›
ALINIA · APRISO · Alinia · Alinia Tablets 500mg 30 count bottle · Amitiza · CLENPIQ · CONMED Biliary · CREON · Cimzia · Creon · DIFICID · DILUMEN · DILUMEN ENDOLUMENAL INTERVENTIONAL PLATFORM · DUPIXENT · ENTYVIO · ESOPHYX · Entyvio · HUMIRA · Humira · IBSRELA · INFLECTRA · LINX Reflux Management System · LINZESS · Linzess · MAVYRET · Mavyret · Motegrity · Movantik · OCALIVA · OMVOH · PANCREAZE · QSYMIA · REBYOTA · REMICADE · RESMETIROM · RINVOQ · SKYRIZI · STELARA · SUPREP · SUPREP BOWEL PREP · SUTAB · Sucraid · TREMFYA · TRULANCE · Talicia · VELSIPITY · VIBERZI · VOQUEZNA · VOWST · WATCHMAN · XELJANZ · XIFAXAN · XIFAXANIBSD · XIFIXAN · ZENPEP · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (60%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in gastroenterology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 9% for gastroenterology in TX.

Equivalent to $2,781 per 100 Medicare services performed
Looking for a gastroenterology in Austin?
Compare gastroenterologys in the Austin area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologys nearby

Geographic Context

Gastroenterologys within 10 mi
67
Per 100K population
5.1
County median income
$97,169
Nearest hospital
AUSTIN OAKS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Havemann is a clinical cardiology specialist, with above-average Medicare volume (top 25% in TX), and high industry engagement (speaking/promotional, top 9%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Havemann experienced with removal of polyps or growths of large bowel using an endoscope with mechanical snare?
Based on Medicare claims data, Dr. Havemann performed 231 removal of polyps or growths of large bowel using an endoscope with mechanical snare services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Havemann receive payments from pharmaceutical companies?
Yes. Dr. Havemann received a total of $26,890 from 43 companies across 528 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Havemann's costs compare to other gastroenterologys in Austin?
Dr. Havemann's average Medicare payment per service is $119. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Havemann) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →